Alphanox Co.,Ltd. (KOSDAQ:043100)

Market Cap	23.21B
Revenue (ttm)	27.36B
Net Income (ttm)	-19.32B
Shares Out	16.58M
EPS (ttm)	-2,754.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,242
Average Volume	39,413
Open	1,372.00
Previous Close	1,372.00
Day's Range	1,340.00 - 1,394.00
52-Week Range	1,340.00 - 6,830.00
Beta	0.11
RSI	37.49
Earnings Date	Mar 20, 2025

About Alphanox

Alphanox Co.,Ltd. manufactures and sells medical devices and healthcare products in South Korea. The company offers surgical instruments, trays and containers, and disposable and custom-made devices; spine, trauma, and joint implants; and in vitro diagnostic devices. It also provides direct, dispenser, and portable type hydrogen water generators; medical devices, such as personal and functional devices, dietary supplements, beauty care products, and pillows. The company was formerly known as Solco Biomedical Co., Ltd. and changed its name to Al...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1974
• Employees: 117
• Stock Exchange: KOSDAQ
• Ticker Symbol: 043100

Financial Performance

In 2023, Alphanox's revenue was 26.88 billion, an increase of 14.88% compared to the previous year's 23.40 billion. Losses were -19.97 billion, 109.6% more than in 2022.